Search by Drug Name or NDC
NDC 00132-0507-24 PHAZYME 750; 250 mg/241; mg/241 Details
PHAZYME 750; 250 mg/241; mg/241
PHAZYME is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by C.B. Fleet Company, Inc.. The primary component is CALCIUM CARBONATE; DIMETHICONE.
MedlinePlus Drug Summary
Calcium carbonate is a dietary supplement used when the amount of calcium taken in the diet is not enough. Calcium is needed by the body for healthy bones, muscles, nervous system, and heart. Calcium carbonate also is used as an antacid to relieve heartburn, acid indigestion, and upset stomach. It is available with or without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00132-0507-24Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Calcium Carbonate
Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00132-0507-24Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Simethicone
Product Information
NDC | 00132-0507 |
---|---|
Product ID | 0132-0507_428c1326-85da-4bc5-a2ae-1f7e10e31ef0 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | PHAZYME |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Simethicone and Calcium Carbonate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 750; 250 |
Active Ingredient Units | mg/241; mg/241 |
Substance Name | CALCIUM CARBONATE; DIMETHICONE |
Labeler Name | C.B. Fleet Company, Inc. |
Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Skin Barrier Activity [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part332 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 00132-0507-24 (00132050724)
NDC Package Code | 0132-0507-24 |
---|---|
Billing NDC | 00132050724 |
Package | 24 TABLET, CHEWABLE in 1 JAR (0132-0507-24) |
Marketing Start Date | 2016-03-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 848d7c23-a12b-49c4-8fda-da15efca33ad Details
Active Ingredients (in each chew)
Uses for the relief of:
When using this product
Ask a doctor or pharmacist before use if you are
Directions
Other Information
Inactive Ingredients
Acacia, beeswax, carnuba wax, citric acid, cornstarch, corn syrup, FD&C red #40 aluminum lake, flavor, modified starch, phosphoric acid, polyvinylpyrolidone, pregelatinized modified corn starch, propylene glycol, shellac, sodium benzoate, sorbic acid, sorbitol, soy lecithin, sucrose, titanium dioxide, vegetable oil, water
Questions?
INGREDIENTS AND APPEARANCE
PHAZYME
simethicone and calcium carbonate tablet, chewable |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - C.B. Fleet Company, Inc. (003119054) |